bronchiectasis hu suping pulmonary department 1st clinical college, wuhan university
DESCRIPTION
Bronchiectasis Hu Suping Pulmonary Department 1st clinical college, Wuhan University. Definition an acquired disorder of the major bronchi and bronchioles characterized by permanent abnormal dilation and destruction of bronchial walls - PowerPoint PPT PresentationTRANSCRIPT
Bronchiectasis
Hu Suping
Pulmonary Department
1st clinical college, Wuhan University
Definition an acquired disorder of the major bronchi and bronchioles characterized by permanent abnormal dilation and destruction of bronchial walls
the most common symptoms are chronic cough with large amounts of purulent sputum and/or recurrent hemoptysis
it involves chronic respiratory tract infection and an up-regulation of the host inflammatory response
Enhanced cellular and mediator responses bronchial mucosal biopsies reveal infiltration by neutrophils and T lymphocytes; expectorated sputum has increased concentrations of elastase and the chemoattractants IL-8, TNFa, and prostanoids
Pathological changes Cylindrical or tubular bronchiectasis: dilated airways alone, sometimes seen as a residual effect of pneumonia
Varicose bronchiectasis: focal constrictive areas along the dilated airways that result from defects in the bronchial wall
Saccular or cystic bronchiectasis: progressive dilatation of the airways, which end in large cysts, saccules, or grape-like clusters (the most severe form )
The lumen of the bronchus is dilated and thThe lumen of the bronchus is dilated and there is prominent chronic inflammation in tere is prominent chronic inflammation in the bronchial wallhe bronchial wall
Bronchiectasis can present in either of two forms — a local or focal obstructive process of a lobe or segment of a lung or a diffuse process involving much of both lungs and often accompanied by other sinopulmonary diseases, such as sinusitis and asthma
Pathophysiology and Etiology
Three types of focal airway obstruction
(1) luminal blockage by a foreign body, broncholith, or slowly growing benign tumor
(2) extrinsic narrowing due to enlarged lymph nodes (middle lobe syndrome)
(3) twisting or displacement of the airways after a lobar resection or chronic infection
Pathophysiology and Etiology
Infections
Childhood respiratory tract infections (pertussis or whooping cough)
Chronic infections( chronic lung abscess, TB)
Primary Ciliary Dyskinesia
an autosomal recessive syndrome, estimated frequency at birth is 1 in 15,000 to 1 in 40,000
half have Kartagener’s syndrome (bronchiectasis, sinusitis, and situs inversus viscerum)
Pathophysiology and Etiology
Immunodeficiency
humoral immunodeficiency syndromes (deficiencies of IgG, IgM, and IgA) at risk for recurrent suppurative sinopulmonary infections and bronchiectasis
immune globulin replacement reduces the frequency of infectious episodes and prevents further destruction of the airways
Clinical findings
Symptoms:
daily cough productive of mucopurulent phlegm
intermittent hemoptysis
recurrent lung infections
shortness of breath
Physical findings:
crackles, cyanosis
Chest radiography
High-resolution computed tomographic scanning (HRCT)
the defining modality for diagnosis of bronchiectasis
Specific abnormalities found on HRCT include
(1) dilatation of an airway lumen > 1.5 times as wide as a nearby vessel
(2) lack of tapering of an airway toward the periphery
(3) varicose constrictions along airways
(4) ballooned cysts at the end of a bronchus
Normal Lung and the Lung of a Patient with Bronchiectasis. Bronchiectasis is primarily in the lower lobe, which is the most common distribution. The saccular dilatations and grapelike clusters with pools of mucus are signs of severe bronchiectasis.
Normal lung Bronchiectasis
Bronchoscopy
an important diagnostic tool to examine for obstruction ( foreign body, tumor, structural deformity, or extrinsic compression from lymph nodes) and to help localize the bleeding , to identify pathogen
Pulmonary function tests
obstructive impairment ( low FEV1 and/or low FEV1/FVC)
airway hyperresponsiveness ( 40% with a positive reversibility test result, and 30% to 69% with a positive bronchial provocative test result)
Diagnostic evaluation
(1) to confirm the diagnosis of bronchiectasis
(2) to identify potentially treatable underlying causes
(3) to provide functional assessment
Imaging of the chest is always necessary to confirm the diagnosis
Differential diagnosis Chronic bronchitis
Lung abscess
Pulmonary tuberculosis
Congenital bronchocele
Diffuse panbronchiolitis
Therapy Control infections: administration of antibiotics
Treatment of underlying conditions
Promotion of bronchial hygiene
Control of bronchial hemorrhage
Surgical therapy
Acute Exacerbations
An exacerbation: including four of the nine symptoms
change in sputum production; increased dyspnea; increased cough; fever (>38.0°C); increased wheezing; malaise, fatigue, lethargy, or decreased exercise tolerance; changes in chest sounds ; reduced pulmonary function; radiographic changes
Early antibiotic therapy: fluoroquinolone as levofloxacin or ciprofloxacin for at least 7 to 10 days
Sputum culture and sensitivity testing: who fail to respond to the initial antibiotic or who have repeated symptomatic attacks in a short interval
Bronchopulmonary HygienePostural drainage, chest physiotherapy, thinning and loosening of secretions, the administration of a bronchodilator and of inhaled corticosteroids –part of maintenance therapy and treatment for acute exacerbations
Hemoptysis
life-threatening hemoptysis: > 600 ml/ day
bronchoscopy or CT of the chest is warranted to help determine which lobe or side is bleeding
interventional radiology: selective bronchial arteries embolization
surgery may be required to resect an area suspected of bleeding
Surgery Removal of an obstructing tumor or residue of a foreign body
Elimination of the segments or lobes the most damaged and suspected of contributing to acute exacerbations, overwhelming viscous secretions, mucous impaction, and plugs
Elimination of areas that are subject to uncontrolled hemorrhage
Removal of damaged lung suspected of harboring problematic organisms such as multidrug-resistant M. tuberculosis or M. avium
Double-lung transplantation is now considered for patients with cystic fibrosis and respiratory failure (one year survival rate 75% and 48% at five years)